CervoMed Inc. Common Stock (CRVO) is a publicly traded Healthcare sector company. As of September 8, 2026, CRVO trades at $2.59 with a market cap of $38.70M and a P/E ratio of -0.80. CRVO moved +0.00% today. Year to date, CRVO is -67.59%; over the trailing twelve months it is -75.64%. Its 52-week range spans $1.92 to $16.94. Analyst consensus is strong buy with an average price target of $15.50. Rallies surfaces CRVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CRVO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $2.59 |
| Market Cap | $38.70M |
| P/E Ratio | -0.80 |
| EPS | $-3.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.94 |
| 52-Week Low | $1.92 |
| Volume | 13.37K |
| Avg Volume | 0 |
| Revenue (TTM) | $331.30K |
| Net Income | $-30.35M |
| Gross Margin | 0.00% |
4 analysts cover CRVO: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.50.